IRIS
CANNAVO', Salvatore
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 13.549
NA - Nord America 11.365
AS - Asia 7.045
SA - Sud America 2.546
AF - Africa 197
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 9
Totale 34.725
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.148
RU - Federazione Russa 7.004
SG - Singapore 3.025
BR - Brasile 2.193
CN - Cina 1.967
IE - Irlanda 1.517
SE - Svezia 1.203
IT - Italia 991
HK - Hong Kong 808
DE - Germania 601
FR - Francia 464
VN - Vietnam 430
UA - Ucraina 428
PL - Polonia 405
GB - Regno Unito 348
FI - Finlandia 289
IN - India 170
AR - Argentina 127
MX - Messico 90
CA - Canada 84
BD - Bangladesh 77
TR - Turchia 74
IQ - Iraq 70
EC - Ecuador 60
ID - Indonesia 54
AT - Austria 51
JP - Giappone 51
PK - Pakistan 51
UZ - Uzbekistan 50
ZA - Sudafrica 48
BE - Belgio 43
NL - Olanda 43
MA - Marocco 40
VE - Venezuela 40
CO - Colombia 39
ES - Italia 36
CL - Cile 26
CZ - Repubblica Ceca 25
KE - Kenya 23
TN - Tunisia 22
SA - Arabia Saudita 20
AE - Emirati Arabi Uniti 19
PH - Filippine 19
PY - Paraguay 18
JO - Giordania 16
PE - Perù 16
CI - Costa d'Avorio 15
MY - Malesia 14
IL - Israele 13
KG - Kirghizistan 13
AZ - Azerbaigian 12
DZ - Algeria 12
LT - Lituania 12
OM - Oman 12
UY - Uruguay 12
BO - Bolivia 11
NP - Nepal 11
AL - Albania 10
AU - Australia 10
KZ - Kazakistan 10
SN - Senegal 9
CR - Costa Rica 8
GR - Grecia 8
JM - Giamaica 8
MD - Moldavia 8
EE - Estonia 7
HU - Ungheria 7
LK - Sri Lanka 7
DO - Repubblica Dominicana 6
EG - Egitto 6
PA - Panama 6
SY - Repubblica araba siriana 6
CH - Svizzera 5
LB - Libano 5
LV - Lettonia 5
QA - Qatar 5
RS - Serbia 5
XK - ???statistics.table.value.countryCode.XK??? 5
BN - Brunei Darussalam 4
BY - Bielorussia 4
GT - Guatemala 4
HR - Croazia 4
KW - Kuwait 4
NG - Nigeria 4
NO - Norvegia 4
NZ - Nuova Zelanda 4
PS - Palestinian Territory 4
SK - Slovacchia (Repubblica Slovacca) 4
TT - Trinidad e Tobago 4
AO - Angola 3
BG - Bulgaria 3
BH - Bahrain 3
CY - Cipro 3
ET - Etiopia 3
EU - Europa 3
GA - Gabon 3
GE - Georgia 3
IR - Iran 3
KH - Cambogia 3
KR - Corea 3
Totale 34.683
Salva come PNG Salva come JPEG
Città #
Moscow 2.085
Ashburn 1.830
Singapore 1.660
Dublin 1.515
Chandler 1.236
Dallas 1.078
Jacksonville 914
Hong Kong 803
Nyköping 695
Beijing 646
San Jose 598
Warsaw 388
The Dalles 366
Messina 365
Princeton 290
Dearborn 274
Los Angeles 268
Lauterbourg 259
Medford 234
Cambridge 228
Des Moines 204
Munich 174
São Paulo 169
New York 164
Buffalo 151
Ann Arbor 136
Boardman 134
Ho Chi Minh City 121
Lancaster 111
Tianjin 108
Wilmington 88
Hanoi 83
Shenyang 72
Rio de Janeiro 71
Santa Clara 69
Belo Horizonte 68
Redondo Beach 66
Jinan 63
Frankfurt am Main 62
San Mateo 60
Nanjing 59
Orem 58
Guangzhou 57
Dong Ket 56
Seattle 50
Brooklyn 48
Council Bluffs 48
Tashkent 47
Hyderabad 46
Rome 46
Helsinki 45
Tokyo 44
Woodbridge 42
Brussels 40
Houston 40
Haikou 39
Nuremberg 37
Curitiba 35
Hebei 35
Jakarta 35
Shanghai 35
Catania 33
London 33
Turku 33
Zhengzhou 32
Brasília 31
Denver 31
Hangzhou 31
Porto Alegre 31
Vienna 31
Bremen 30
Shenzhen 30
Manchester 28
Mexico City 28
Chennai 27
Johannesburg 27
Nanchang 27
Baghdad 26
Amsterdam 25
Atlanta 25
Ningbo 25
Stockholm 25
Chicago 24
Montreal 24
Campinas 22
Milan 22
Pune 22
Turin 22
Fortaleza 20
Nairobi 20
Ribeirão Preto 20
Salvador 20
Ankara 19
Poplar 19
Toronto 19
Düsseldorf 18
Falls Church 18
Goiânia 18
Guayaquil 18
Lahore 18
Totale 19.820
Salva come PNG Salva come JPEG
Nome #
La chirurgia tiroidea transorale 264
Aggressive pituitary adenomas: the dark side of the moon 252
Acromegaly is more severe in patients with AHR or AIP gene variants living in highly polluted areas 246
Cardiovascular outcomes and conventional risk factors in nondiabetic adult patients with GH deficiency: a long-term retrospective cohort study 224
Acne ed irsutismo: patologie endocrine? 213
A 53-year-old woman with Cushing's disease and a pituitary tumor 206
Clinical management of critically ill patients with Cushing's disease due to ACTH-secreting pituitary macroadenomas: effectiveness of presurgical treatment with pasireotide 205
Cardiovascular events in acromegaly: distinct role of Agatston and Framingham score in the 5-year prediction. 204
ACROSCORE: a new and simple tool for the diagnosis of acromegaly, a rare and underdiagnosed disease 199
Cyberknife stereotactic treatment of pituitary adenomas: A single center experience using different irradiation schemes and modalities 198
A case of clinically silent acromegaly with erectile dysfunction. 195
Peptide receptor radionuclide therapy for aggressive pituitary tumors: a monocentric experience 192
Diabetes secondary to acromegaly: Physiopathology, clinical features and effects of treatment 190
Abnormalities of hypothalamic-pituitary-thyroid axis in patients with primary empty sella 187
Global Cushing's disease epidemiology: a systematic review and meta-analysis of observational studies 187
L’apoplessia ipofisaria: riconoscerla rapidamente e trattarla correttamente. 186
Acromegaly is associated with increased cancer risk: a survey in Italy 180
Acromegaly, genetic variants of the aryl hydrocarbon receptor pathway and environmental burden 180
Course of Pregnancy in Cushing Disease under Different Management Approaches (No Treatment, Surgery, Gamma-Knife or Ketoconazole) 179
Peptide receptor radionuclide therapy with 111IN-DTPA-Octreotide in a woman with Cabergoline-resistant giant prolactinoma 178
Global epidemiology of acromegaly: A systematic review and meta-analysis 178
An extremely rare association of TSH-secreting pituitary adenoma, metastatic neuroendocrine tumor and Cushing’s syndrome in a patient with MEN-1 gene mutation 177
Deficit di ormone della crescita e sindrome metabolica: effetti del trattamento sostitutivo a lungo termine con GH ricombinante in età adulta. 176
P-57 Increased prevalence of acromegaly in an industrialized area of north-east of Sicily: a case-control study 176
Acromegalic cardiopathy: a morphofunctional study with color-Doppler echocardiography 176
Effectiveness and safety of long-term pegvisomant administration in patients with acromegaly not controlled by other therapies: experience of an Italian center. 174
Analysis of GPR101 and AIP genes mutations in acromegaly: a multicentric study 174
A novel point mutation in the ligand-binding domain of the human glucocorticoid receptor (hGR)in a patient with glucocorticoid resistance 173
Increased prevalence of acromegaly in a highly polluted area. 173
Comment to ‘glucocorticoid resistance syndrome caused by a novel nr3c1 point mutation’ by al argan et al. 173
High bone marrow fat in patients with Cushing’s syndrome and vertebral fractures 172
Pasireotide treatment reduces cardiometabolic risk in Cushing's disease patients: an Italian, multicenter study 172
PRIMARY EMPTY SELLA IS ASSOCIATED WITH INCREASED CARDIOVASCULAR RISK, REGARDLESS THE OCCURRENCE OF PITUITARY DYSFUNCTION 170
Effects of cyberknife radiotherapy treatment of pituitary adenomas 170
Analisi dell'intervallo QT all'ECG di superficie in pazienti affetti da deficit primario di GH con e senza ipertrofia ventricolare sinistra 168
Increased serum interleukin-22 levels in patients with PRL-secreting and non-functioning pituitary macroadenomas. 168
Oxidative stress as a key feature of autoimmune thyroiditis: an update 168
Dioxin-like pentachlorobiphenyls promote extra-cellular matrix remodeling by increasing the expression of endothelial cell-specific molecule 1 and metalloproteinases, and induce epigenetic modifications in thyrocytes 166
Adverse childhood experiences and negative emotional responses : risk factors for thyroid autoimmune diseases? 166
Increased prevalence of restless legs syndrome in patients with acromegaly and effects on quality of life assessed by Acro-QoL. 165
Characteristics of a nationwide cohort of patients presenting with isolated hypogonadotropic hypogonadism (IHH) 165
Alemtuzumab-induced thyroid events in multiple sclerosis: a systematic review and meta-analysis 165
GSTP1 gene methylation and AHR rs2066853 variant predict resistance to first generation somatostatin analogs in patients with acromegaly 164
Abnormalities of GH secretion in a young girl with Floating-Harbor syndrome 163
MRI finding of simultaneous coexistence of growth hormone-secreting pituitary adenoma with intracranial meningioma and carotid artery aneurysms: report of a case 163
Lymphocytic hypophysitis: differential diagnosis and effects of high-dose pulse steroids, followed by azathioprine, on the pituitary mass and endocrine abnormalities--report of a case and literature review. 162
Increased frequency of the rs2066853 variant of aryl hydrocarbon receptor gene in patients with acromegaly 162
Atrial parasystole in left ventricular noncompaction: a morphofunctional study by echocardiography and magnetic resonance imaging. 160
Abnormal daily periodicity of serum thyrotropin (TSH) and evidencefor defective TSH suppression in a case of non-neoplastic syndrome ofinappropriate TSH secretion. 160
Course of pregnancies in women with Cushing's disease treated by gamma-knife 160
Methylome Analysis in Nonfunctioning and GH-Secreting Pituitary Adenomas 159
Predictive markers of recurrence in radically resected pituitary macroadenomas 157
Association between pain, arthropathy and health-related quality of life in patients suffering from acromegaly. A cross-sectional study 155
Epidemiologia degli adenomi ipofisari nel nord-est della Sicilia 155
Trattamento di tumori ipofisari mediante Cyber-Knife: Dati preliminari a medio termine su efficacia e sicurezza 155
HGF/c-met system targeting PI3K/AKT and STAT3/phosphorylated-STAT3 pathways in pituitary adenomas: an immunohistochemical characterization in view of targeted therapies. 155
Cardiometabolic Risk in Acromegaly: A Review With a Focus on Pasireotide 153
Mitotane Concentrations Influence the Risk of Recurrence in Adrenocortical Carcinoma Patients on Adjuvant Treatment 153
Multidisciplinary management of pituitary apoplexy 152
A novel point mutation in the ligand-binding domain of the human glucocorticoid receptor (hGR) in a patient with glucocorticoid resistance. 152
Modificazione del pattern secretivo, dopo chirurgia, e dei marker proliferativi cellulari, dopo radioterapia (gamma-knife), in un corticotropinoma invasivo. 151
MTHFR C677T polymorphism, folate status and colon cancer risk in acromegalic patients. 151
Adrenal Cushing Syndrome: Diagnosis and Management in a 10-Year-Old Boy with Carney Complex 150
Resistance to somatostatin analogues is associated with GSTP1 gene methylation and AHR rs2066853 variant in acromegaly patients 150
Biochemical control and clinical improvement is induced by long-term pasireotide administration in the majority of patients with Cushing[apos]s disease persistent after pituitary surgery 150
Dissociated responsiveness of a growth hormone- and thyrotropin-secreting pituitary adenoma to octreotide-long-acting release therapy: The intriguing case of Mister B. 148
Commentary on "Co-Occurrence of Pituitary Adenoma With Suprasellar and Olfactory Groove Meningiomas" 148
N-terminal pro-brain natriuretic peptide determination as a possible marker of cardiac dysfunction in patients with adrenal disorders 146
MicroRNAs expression in pituitary tumors: differences related to functional status, pathological features, and clinical behavior 146
Acromegaly and coronary disease: An integrated evaluation of conventional coronary risk factors and coronary calcifications detected by computed tomography 145
Adrenocorticotropin responsiveness to acute octreotide administration is not affected by mifepristone premedication in patients with Cushing's disease. 145
Effects of pasireotide treatment on cardio-metabolic risk in patients with Cushing's disease: an Italian, multicenter study 145
Subcutaneous lipoatrophy induced by long-term pegvisomant administration in a patient with acromegaly. 143
Cystic Fibrosis as a Cause of Malabsorption and Increased Requirement of Levothyroxine 143
Increased interleukin 22 circulating levels in patients with tumors involving the hypothalamic-pituitary region 142
Thyroid nodules in growth hormone replaced patients. 142
First report on persistent remission of acromegaly after withdrawal of long-term pegvisomant monotherapy 142
Establishment of a protocol to extend the lifespan of human hormone-secreting pituitary adenoma cells 142
Endocrine and metabolic adverse effects of immune checkpoint inhibitors: an overview (what endocrinologists should know) 141
Effects of GH replacement therapy on thyroid volume and nodule development in GH deficient adults: a retrospective cohort study 139
An unusual case of idiopathic hyperprolactinemia 138
How to improve effectiveness of pegvisomant treatment in acromegalic patients 136
The role of inferior petrosal sinus sampling in ACTH-dependent Cushing's syndrome: review and joint opinion statement by members of the Italian Society for Endocrinology, Italian Society for Neurosurgery, and Italian Society for Neuroradiology 136
A New Clinical Model to Estimate the Pre-Test Probability of Cushing’s Syndrome: The Cushing Score 136
Non-functioning pituitary adenomas infrequently harbor G-protein gene mutations. 135
Temozolomide-induced shrinkage of a pituitary carcinoma. 135
Peptide receptor radionuclide therapy (PRRT) in patients with giant aggressive pituitary tumors: experience of an Italian referral center and review of literature 135
Environmental Endocrinology and Endocrine Disruptors: Environmental Impact on the Hypothalamus–Pituitary Axis 134
Increased serum brain natriuretic peptide levels are a major predictor of myocardial hypertrophy in acromegalic patients. 134
Spontaneous intermittent MRI changes of a pituitary stalk lesion causing diabetes insipidus and amenorrhea 134
Modificazione dei parametri di rischio cardiovascolare durante trattamento sostitutivo prolungato con ormone della crescita 133
Effects Of Epigenetic Changes In Gstp1 And Mgmt Gene On Clinicopathological Fatures Of Acromegaly Patients 133
Subcutaneous lipoatrophy induced by long-term pegvisomant administration 132
Pituitary atypical teratoid rhabdoid tumor in a patient with prolactinoma: A unique description 132
Genetic and epigenetic modulation of AHR pathway in GH-secreting pituitary tumors and effects on acromegaly clinical phenotype 131
Primary growth hormone insensitivity (Laron syndrome) and acquired hypothyroidism: a case report 131
Abnormal responses to vasoactive intestinal peptide and corticotropin releasing hormone during thespontaneous remission of Cushing's disease. 129
Vitamin D receptor gene polymorphisms/haplotypes and serum 25(OH)D3 levels in Hashimoto's thyroiditis. 129
Epidemiology, course, and outcomes of Sars-CoV-2 infection in patients with acromegaly and Cushing’s disease: a monocentric experience in Southern Italy 128
Global psychological assessment with the evaluation of life and sleep quality and sexual and cognitive function in a large number of patients with acromegaly: a cross-sectional study 128
Totale 16.238
Salva come PNG Salva come JPEG
Categoria #
all - tutte 117.113
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 117.113
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021177 0 0 0 0 0 0 0 0 0 0 72 105
2021/20221.699 15 219 31 95 50 23 85 75 41 205 243 617
2022/20234.670 394 357 202 384 323 477 88 295 1.847 47 197 59
2023/20241.199 111 213 98 108 111 212 20 104 4 65 7 146
2024/20256.031 101 83 162 316 337 139 171 1.308 1.563 382 473 996
2025/202616.583 773 1.038 1.298 1.050 1.482 3.708 2.167 2.021 2.080 779 187 0
Totale 35.496